EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

TDP‐43 Aggregation: The Healthy‐Toxic Balance of the Prion‐Like Domain

Luca Zangrando, Emanuele Buratti iD, Francesca Paron

Advanced Science · 2026

DOI: 10.1002/advs.76119 ↗

At a glance

Übersichtsarbeit in Advanced Science, 2026. Written by Luca Zangrando and 2 co-authors. Institution: Life Science Department, University of Trieste, Trieste, Italy. Major MEDLINE topics: Protein Aggregation, Pathological, DNA-Binding Proteins, RNA-Binding Proteins, Prions. Cited 1 times so far (Crossref); 267 references. The full text is freely available (open access, CC BY 4.0). Funded by: AriSLA 2022-NOSRESCUEALS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

TAR DNA‐binding protein 43 (TDP‐43) is a ubiquitously expressed RNA‐binding protein that plays essential roles in RNA metabolism, including transcription, splicing, transport, and stability. Pathological TDP‐43 aggregates have become a defining hallmark of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and a large subset of frontotemporal lobar degeneration (FTLD). In the last decade, increasing evidence has challenged the initial thought of TDP‐43 condensates as a purely pathological event, highlighting instead the physiological relevance of reversible self‐association, polymerization and liquid‐liquid phase separation (LLPS) in regulating TDP‐43 functions. In this review, we provide an integrated overview of the structural determinants governing TDP‐43 two‐faced polymerization, with a particular focus on the prion‐like domain and its parallelism with prion proteins. Indeed, while physiological assemblies support normal RNA processing, the dysregulation of LLPS by either disease‐associated mutations, altered RNA‐binding, aberrant post‐translational modifications, or proteolytic cleavage can promote the transition toward irreversible, pathogenic aggregates. Finally, we summarize strategies aimed at eliminating TDP‐43 aggregates or modulating its phase‐separation behavior. Altogether, this review frames TDP‐43 polymerization in both healthy and pathological conditions, offering a prion‐like centered view of TDP‐43 proteinopathies.

Subjects

MeSH terms (MEDLINE)

Protein Aggregation, PathologicalDNA-Binding ProteinsRNA-Binding ProteinsPrionsRNA Processing, Post-TranscriptionalNeurodegenerative DiseasesProtein AggregatesProtein DomainsPhase SeparationMutationProtein Processing, Post-TranslationalProteolysisPolymerizationHumansTDP-43 Proteinopathies

Author keywords

LLPSTDP‐43neurodegenerationprion‐like domainprotein aggregationtherapeutic strategies

Substances

TARDBP protein, humanDNA-Binding ProteinsRNA-Binding ProteinsPrionsProtein Aggregates

Authors and institutions

  • Life Science Department, University of Trieste, Trieste, Italy.
  • Molecular Pathology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.

ORCID profiles: Emanuele Buratti

Funding

  • AriSLA 2022-NOSRESCUEALS

Cite

APA

Zangrando, L., Buratti, E., & Paron, F. (2026). TDP‐43 Aggregation: The Healthy‐Toxic Balance of the Prion‐Like Domain. Advanced Science. https://doi.org/10.1002/advs.76119

Vancouver

Zangrando L, Buratti E, Paron F. TDP‐43 Aggregation: The Healthy‐Toxic Balance of the Prion‐Like Domain. Advanced Science. 2026. doi:10.1002/advs.76119

BibTeX
@article{Zangrando2026,
  author = {Zangrando, Luca and Buratti, Emanuele and Paron, Francesca},
  title = {TDP‐43 Aggregation: The Healthy‐Toxic Balance of the Prion‐Like Domain},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76119}
}
Start for free →